Although Trp53 disruption mainly led to the development of acinar and undifferentiated pancreatic tumors, those histologically similar to human pancreatic ductal adenocarcinomas (PDAC) were observed in the Trp53 null mice with homozygous and heterozygous Brca2 mutations. This evidence concerns the gene BRCA2 and pancreatic neoplasm.